Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity.
Hyaluronic Acid-Glycine-Cholesterol Conjugate-Based Nanoemulsion as a Potent Vaccine Adjuvant for T Cell-Mediated Immunity.
复制标题
DOI:
10.3390/pharmaceutics13101569
复制
发表时间:
2021-09-27
期刊:
影响因子:
5.4
通讯作者:
Lai PS
中科院分区:
文献类型:
--
作者:
Lin CA;Ho HM;Venkatesan P;Huang CY;Cheng YJ;Lin YH;Lin HY;Chen TY;Huang MH;Lai PS
Clinical cases of allergic reaction that are due to excipients containing polyethylene glycol (PEG), a hydrophilic molecule commonly used in drug/vaccine formulations, has attracted much attention in recent years. In order to develop PEG-free adjuvants, we investigated the feasibility of natural ingredients in the human body such as hyaluronic acid in the form of hyaluronic acid-glycine cholesterol (HACH) conjugate as an excipient for vaccine formulation. Interestingly, HACH grafted with ~13 wt.% cholesterol has good water dispersity and can serve as an emulsifier to stabilize the squalene/water interfaces, yielding a milky white and isotropic emulsion (SQ@HACH) after being passed through a high-shear microfluidizer. Our results show that SQ@HACH particles possessed a unimodal average hydrodynamic diameter of approximately 190 nm measured by dynamic light scattering and exhibited good stability upon storage at 4 °C and 37 °C for over 20 weeks. The results of immunogenicity using a mouse model with ovalbumin (OVA) as the antigen revealed that SQ@HACH significantly enhanced antigen-specific immune responses, including the polarization of IgG antibodies, the cytokine secretions of T cells, and enhancement of cytotoxic T lymphocyte (CTL) activation. Moreover, SQ@HACH revealed lower local inflammation and rapidly absorbing properties compared with AlPO4 after intramuscular injection in vivo, indicating the potential functions of the HA-derived conjugate as an excipient in vaccine formulations for enhancement of T cell-mediated immunity.
登录
查看更多内容
影响因子:
5.5
作者:
Fieber, Wolfgang;Herrmann, Andreas;Sommer, Horst
通讯作者:
Sommer, Horst
影响因子:
3
作者:
Harvima, Ilkka T.;Heikura, Hanna;Naukkarinen, Anita
通讯作者:
Naukkarinen, Anita
影响因子:
5.1
作者:
AL-Deen, F. M. Nawwab;Selomulya, C.;Plebanski, M.
通讯作者:
Plebanski, M.
DOI:
10.1016/b978-0-12-817778-5.00007-5
发表时间:
2020-01-17
期刊:
Nanopharmaceuticals
影响因子:
--
作者:
Diaz-Arévalo D;Zeng M
通讯作者:
Zeng M
影响因子:
24.1
作者:
Fang, Hongliang;Ang, Bing;Wan, Tao
通讯作者:
Wan, Tao